Endo Designated Activity Company, a designated activity company limited by shares incorporated under the laws of Ireland (“Endo DAC”), Endo Finance LLC, a Delaware limited liability company, and Endo Finco Inc., a Delaware corporation, both wholly-owned subsidiaries of Endo DAC, formed as special purpose finance vehicles (together, the “Endo Finance Issuers”, and collectively with Endo DAC, the “Issuers”) have issued $300,000,000 principal amount of their 5.875% senior notes due 15 October 2024 (the “Notes”) namely;

(i) $292,535,000 principal amount originally issued pursuant to Rule 144A under the U.S Securities Act of 1933, as amended (the “Securities Act”) (CUSIP: 29273D AA8; ISIN: US29273DAA81);

(ii) $ 7,465,000 principal amount originally issued pursuant to Regulation S under the Securities Act (CUSIP: G30407 AA1; ISIN: USG30407AA14).